Compare Cardinal Health Inc (CAH) vs VNET Group Inc (VNET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs VNET Group Inc — how do they compare? Cardinal Health Inc trades at $228.96 (market cap $53.89B), while VNET Group Inc trades at $7.92 (market cap $2.21B). The key difference: Cardinal Health Inc is far larger — about 24.4× VNET Group Inc's market cap, and Cardinal Health Inc pays a 0.89% dividend while VNET Group Inc pays none. Which is the better fit depends on your goals.
| CAH | VNET | |
|---|---|---|
Market Cap | $53.89B | $2.21B |
Sector | Health | Technology |
52-Week High | $239.71 | $14.03 |
52-Week Low | $146.04 | $7.34 |
Enterprise Value | $58.87B | $5.34B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
VNET Group trades at $7.72, down 3.62% on the day, with a bearish technical signal and negative earnings momentum after missing Q1 2026 EPS estimates. The company reported a net loss of $256.77 million in 2025, with profitability metrics like ROE at -43.21% indicating financial strain. However, revenue grew to $9.95 billion, and analyst sentiment remains largely positive with a 62.5% buy rating, citing AI-driven demand and new strategic investments from entities linked to CATL.
The outlook is mixed: strong revenue growth and strategic positioning in data centers offer upside, but persistent losses and high debt pose significant risks. Investors should weigh the potential from AI expansion against execution challenges and financial health concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →
